通过数字疗法重新考虑下肢外周动脉疾病管理:A PESTEL和SWOT/TOWS分析
Laurence Destrieux1, Bahaa Nasr2, Fabien Thaveau3
1Département de Chirurgie Vasculaire, Clinique Générale, Groupe Vivalto, Annecy, France.
Annals of vascular surgery
|December 5, 2025
概括
在法国,针对外围动脉疾病 (PAD) 开发数字疗法 (DTx) 需要解决医疗保健系统的挑战. 关键的设计元素包括患者教育和护士领导的后续工作,以改善坚持和结果.
科学领域:
- 心血管医学 心血管医学
- 医疗信息学 医疗信息学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 周围动脉疾病 (PAD) 是一种广泛的血管疾病,具有显著的发病率,死亡率和成本.
- 患者对当前治疗方法的不理想坚持阻碍了有效的PAD管理.
- 数字治疗 (DTx) 为患者慢性疾病的自我管理提供了创新的解决方案.
研究的目的:
- 确定开发DTx的重要组成部分,以防止法国PAD患者的不良结果.
- 分析影响PAD的DTx实施的宏观环境因素.
主要方法:
- 使用政治,经济,社会文化,技术,环境,法律 (PESTEL) 和优势,弱点,机会,威胁 (SWOT) /威胁,机会,弱点,优势 (TOWS) 框架进行结构化审查.
- 对DTx在PAD中的宏观环境驱动因素,系统约束和实施机会的评估.
主要成果:
- PESTEL分析揭示了预防,门诊护理,劳动力,补偿和经济/环境负担方面的挑战,以及政策,远程监控准备和公共利益方面的机遇.
- SWOT/TOWS分析表明,DTx有潜力提高执法,简化门诊护理,减少工作量,解决劳动力短缺问题.
- 基本的DTx设计特征包括患者教育,行为推动,多式联络数据输入和护士领导的随访.
结论:
- PESTEL和SWOT/TOWS分析为在法国开发以PAD为中心的DTx提供了一个框架.
- 拟议的DTx旨在改善遵守,减少住院治疗,并支持公共卫生目标.
- 需要进一步的临床验证;这种方法可以适应其他国家和慢性心血管疾病.
更多相关视频
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
1.9K
10:50Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
12.7K
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
01:26Peripheral Artery Disease IV: Nursing Management
321
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
321
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
326
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
326
01:23Peripheral Artery Disease V: Postoperative Nursing Management
354
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
354
01:30Peripheral Artery Disease I: Introduction
290
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
290
01:26Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296